BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3154835)

  • 1. A clinical and chromosomal study on those exposed to the atomic bomb and their offspring.
    Chung JM; Choe HJ
    Korean J Intern Med; 1987 Jul; 2(2):227-33. PubMed ID: 3154835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation research at ABCC/RERF: cytogenetic studies of atomic bomb exposed populations.
    Awa A
    Mutat Res; 2003 Jan; 543(1):1-15. PubMed ID: 12510014
    [No Abstract]   [Full Text] [Related]  

  • 3. Radioactive fallout effects of the Nagasaki atomic bomb.
    Okajima S; Takeshita K; Antoku S; Shiomi T; Russell WJ; Fujita S; Yoshinaga H; Neriishi S; Kawamoto S; Norimura T
    Health Phys; 1978 Jun; 34(6):621-33. PubMed ID: 103862
    [No Abstract]   [Full Text] [Related]  

  • 4. Chromosome analysis of bone marrow fibroblast colony-forming cells (CFU-F) in heavily exposed atomic bomb survivors.
    Shigeta C; Tanaka K; Kawakami M; Ohkita T
    Hiroshima J Med Sci; 1984 Dec; 33(4):659-62. PubMed ID: 6534923
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose revision for A-bomb survivors and the question of fallout contribution.
    Schmitz-Feuerhake I
    Health Phys; 1983 Jun; 44(6):693-5. PubMed ID: 6853199
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiation exposure and thyroid disease in Hiroshima and Nagasaki atomic bomb survivors.
    Völzke H; Hoffmann W
    JAMA; 2006 Aug; 296(5):512; author reply 512-3. PubMed ID: 16882953
    [No Abstract]   [Full Text] [Related]  

  • 7. [The cytogenetic effects in the population of the Altai Territory subjected to ionizing radiation exposure as a result of the nuclear explosions at the Semipalatinsk proving grounds].
    Shevchenko VA; Snigireva GP; Suskov II; Akaeva EA; Elisova TN; Iofa EL; Nilova IN; Kostina LN; Novitskaia NN; Sidorova VF
    Radiats Biol Radioecol; 1995; 35(5):588-96. PubMed ID: 7489088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The results of the cytogenetic examination of the inhabitants of population centers adjacent to the Semipalatinsk nuclear testing grounds (at the period of the work of the interdepartamental commission in 1989)].
    Sevan'kaev AV; Ankina MA; Golub EV; Zhlova AA; Zavitaeva TA; Kozlov VM; Mikhaĭlova GF; Moiseenko VV; Pozdyshkina OV; Potetnia OI
    Radiats Biol Radioecol; 1995; 35(5):596-607. PubMed ID: 7489089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A-bomb data: detection of bias in the Life Span Study cohort.
    Stewart A
    Environ Health Perspect; 1997 Dec; 105 Suppl 6(Suppl 6):1519-21. PubMed ID: 9467075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in assessing the public health impact from residues of nuclear bomb testing in Kazakhstan.
    Grosche B
    J Radiol Prot; 2005 Jun; 25(2):123-4. PubMed ID: 15942054
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer in Japanese A-bomb survivors.
    Tokunaga M; Land CE; Yamamoto T; Asano M; Tokuoka S; Ezaki H; Nishimori I
    Lancet; 1982 Oct; 2(8304):924. PubMed ID: 6126762
    [No Abstract]   [Full Text] [Related]  

  • 12. [Health effects of atomic bomb radiation].
    Shigematsu I
    Rinsho Byori; 1994 Apr; 42(4):313-9. PubMed ID: 8176838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics. DNA mutations linked to Soviet bomb tests.
    Stone R
    Science; 2002 Feb; 295(5557):946. PubMed ID: 11834788
    [No Abstract]   [Full Text] [Related]  

  • 14. Sister chromatid exchanges in peripheral lymphocytes of atomic bomb survivors and of normal individuals exposed to radiation and chemical agents.
    Pant GS; Kamada N; Tanaka R
    Hiroshima J Med Sci; 1976 Sep; 25(2-3):99-105. PubMed ID: 1026669
    [No Abstract]   [Full Text] [Related]  

  • 15. Pituitary tumors following fallout radiation exposure.
    Adams WH; Harper JA; Rittmaster RS; Grimson RC
    JAMA; 1984 Aug; 252(5):664-6. PubMed ID: 6737672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver function in survivors of the atomic bomb.
    Gregory PB; Amamoto K; Archer PG; Rickert RR; Omori Y; Bizzozero OJ; Hamilton HB; Johnson KG
    Radiat Res; 1975 Sep; 63(3):578-83. PubMed ID: 1162040
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Thyroid cancer rates and (131)I doses from Nevada atmospheric nuclear bomb tests.
    Archer VE
    J Natl Cancer Inst; 1999 Aug; 91(16):1423-5. PubMed ID: 10451455
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure.
    Imaizumi M; Usa T; Tominaga T; Neriishi K; Akahoshi M; Nakashima E; Ashizawa K; Hida A; Soda M; Fujiwara S; Yamada M; Ejima E; Yokoyama N; Okubo M; Sugino K; Suzuki G; Maeda R; Nagataki S; Eguchi K
    JAMA; 2006 Mar; 295(9):1011-22. PubMed ID: 16507802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cover-up of the effects of internal exposure by residual radiation from the atomic bombing of Hiroshima and Nagasaki.
    Sawada S
    Med Confl Surviv; 2007; 23(1):58-74. PubMed ID: 17370859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radioactive fallout after reactor accidents and nuclear weapons testing].
    Lote K; Klepp O; Reitan JB
    Tidsskr Nor Laegeforen; 1986 Aug; 106(23):1836-40. PubMed ID: 3764861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.